My Techniques for Shoulder Joint Preservation
•
8 recomendaciones•5,844 vistas
A presentation on different techniques for shoulder joint preservation in regards to the advances in technology for rotator cuff pathology, from tendonitis to cuff tear arthropathy.
Recomendados
Más contenido relacionado
La actualidad más candente
La actualidad más candente (20)
Destacado
Destacado (15)
Similar a My Techniques for Shoulder Joint Preservation
Similar a My Techniques for Shoulder Joint Preservation (20)
Más de Alan M. Hirahara, M.D., FRCSC
Más de Alan M. Hirahara, M.D., FRCSC (20)
Último
Último (20)
My Techniques for Shoulder Joint Preservation
- 1. My Techniques for Shoulder Joint Preservation Alan M. Hirahara, M.D., FRCS(C) Board Certified in Orthopaedic Surgery & Orthopaedic Sports Medicine Specializing in arthroscopic shoulder & knee surgery
- 2. Historical View of Rotator Cuff Pathology Diagnosis • Tendonitis / Impingement • Rotator cuff tear Treatment • Conservative treatment • Surgical treatment – Decompression – Open rotator cuff repair
- 3. Prehistoric The Future • Orthopaedic Surgeons – –
- 4. Spectrum of Rotator Cuff Disease • Tendonitis / Low grade PASTA lesion • High grade PASTA lesion / Rotator cuff tear • Reparable massive rotator cuff tear • Irreparable rotator cuff tear • Cuff tear arthropathy
- 5. TENDONITIS & LOW GRADE PARTIAL CUFF TEAR
- 6. Options for Tendonitis / Low-Grade Partial RC Tear Traditional • • Physical Therapy • Cortisone • Surgery – Decompression / Acromioplasty – Debridement Advanced Technology • Platelet-rich plasma (PRP) • Stem cells (BMAC) (?)
- 7. Goals of Treatment • Decrease pain & inflammation • Create vascular channels • Promote stem cell migration • Achieve healing of tissue B A B 1.5 1 0.5 0 CONTROL ACP HA LOG HAS-2 FOLD CHANGE OVER CONTROL HA IN SYNOVIOCYTES 20 10 MMP 13-IN SYNOVIOCYTES A B A 0 -1 -2 CONTROL ACP HA LOG MMP-13 FOLD CHANGE OVER CONTROL A B B 0 CONTROL ACP HA TNF-Α (PG/ML) TNF- Α Fortier et al, AJSM, 2014
- 8. Stem Cells Proliferation & Migration Significantly Increased with PRP – Kakudo et al, Plast Recontr Surg 2008 – Zaky et al, J Tissue Eng Regen Med 2008 – Drengk et al, Cells Tissues Organs 2009 – Mishra et al, Tissue Eng Part C Methods 2009 – Kruger et al, J Orthop Res 2012 – Moreira Teixeira et al, Biomaterials 2012 – Murphy et al, Biomaterials 2012 – Hildner et al, J Tissue Eng Regen Med 2013
- 9. Platelet-Rich Plasma vs. Cortisone Injections for the Non-surgical Treatment of Shoulder Pain PRP > Cortisone • Inflammatory & calcific processes – Tendonopathy • Partial tears & degenerative processes – Tendon, ligament, muscle • Pain relief PRP = Cortisone • Full thickness tears – Rotator cuff, SLAP, instability • Adhesive capsulitis • Advanced DJD of shoulder • 740 patients with injection of cortisone or PRP (ACP) under ultrasound guidance • 208 Study (PRP) patients / 532 Control (cortisone) patients
- 10. Type of Tendonopathy Will Determine Mode of Treatment • Inflammatory (Tendonitis) • Degenerative • Partial tear – Acute traumatic – Semi-acute non-traumatic – Chronic • Full tear • Peri-tendon / One • Intra-tendon / One+ – Intra-tendon / One – Intra-tendon / One+ – Intra-tendon / 2 or 3 • Peri-tendon / One
- 11. Other Considerations • h/o Cortisone • In season • Out of season • Multiple injections • Peri-tendon / Pain control • Attempt to heal
- 12. Injecting to Heal • Degenerative tendons – Lat / Med epicondylitis – Patellar / Quad tendonitis – Achilles tendonitis • Partial tears of ligaments – UCL – MCL – NOT Intra-articular ligaments or tendons • Calcific tendons – Rotator cuff – Patellar – Achilles
- 13. HIGH GRADE PARTIAL CUFF TEAR & REPAIRABLE FULL-THICKNESS RC TEAR
- 14. Options for High Grade PASTA Lesion Traditional • Debridement • Decompression / Acromioplasty • Repair – – Trans-osseous repair – Trans-tendon repair Advanced Technology • PASTA Bridge • Platelet-rich plasma (PRP) • Stem cells (BMAC) • FlexiGraft DBM sponge
- 15. Options for Repairable Cuff Tear Traditional • Repair – Trans-osseous – Suture anchors – SutureBridge Advanced Technology • SpeedFix • SpeedBridge • Platelet-rich plasma (PRP) • Stem cells (BMAC) • FlexiGraft DBM sponge
- 16. PASTA Bridge Technique • Percutaneous • Safer • Improved Construct
- 17. Extension Bridge
- 18. SpeedBridge • FiberTape – Tissue pull through • Vented Swivelocks – BioComposite material – Full thread anchors – Cannulation • Improved Accessories – FastPass Scorpion – PassPorts – Synergy • Improved Construct – Knotless Technology
- 19. FlexiGraft DBM Sponge • Partially demineralized cancellous sponges – Ground – Cubes – Strips • Demineralized cortical fibers
- 20. FlexiGraft DBM Sponge • DBM produced significantly more fibrocartilage & mineralized fibrocartilage at 12- week post-op, showing a more mature, organized tendon-bone interface Sundar et al., J Biomed Mater Res. 2009; 88B: 115- 122 Sundar et al., J Bone Joint Surg Br. 2009;91;(9)1257- 62
- 21. FlexiGRAFT with RC Repair James Cook, DVM, PhD • Chronic infraspinatus model – n = 10 dogs – Bilateral shoulders, release tendon – Repair after 4 wks • FlexiGRAFT / PRP vs. Direct Repair – Modified SpeedFix configuration • SutureTak medially • 12 week sacrifice, outcome measures – MRI, Histo, and Biomechanical testing
- 22. FlexiGRAFT Strip with RC Repair Standard FlexiGRAFT T = Tendon; I = Interface; A = Anchor Standard has more fibrous tissue at interface and is more edematous
- 23. FlexiGRAFT Strip with RC Repair Standard FlexiGRAFT
- 24. FlexiGRAFT Strip with RC Repair (Lower = Better, both are significant)
- 26. FlexiGraft PASTA Bridge 2nd Look 5 mos post-op
- 27. Case • PASTABridge with FlexiGraft 9/2012 • 2nd Look 2/2013
- 28. Results - PASTABridge Pain Scores ASES Scores 100.0 90.0 80.0 70.0 60.0 50.0 40.0 30.0 20.0 10.0 0.0 Pre-op 1 Control Group: n = 35 Study Group: n = 12 Month 2 Month 3 Month 4 Month 5 Month 6 Month 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0 Pre-op 1 Month 2 Month 3 Month 4 Month 5 Month 6 Month
- 29. SpeedBridge Augmented with FlexiGraft
- 30. SpeedBridge with FlexiGraft A Better Way
- 31. Results - SutureBridge Pain Scores 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0 Pre-op 1 Month 2 Month 3 Month 4 Month 5 Month 6 Month ASES Scores 100.0 90.0 80.0 70.0 60.0 50.0 40.0 30.0 20.0 10.0 0.0 Pre-op 1 Month 2 Month 3 Month 4 Month 5 Month 6 Month Control Group: n = 45 Study Group: n = 7
- 32. REPAIRABLE LARGE-MASSIVE ROTATOR CUFF TEAR
- 33. Options for Repairable Massive Tear Traditional • Repair – Trans-osseous – Suture anchors – SutureBridge Advanced Technology • SpeedBridge • Rip Stop • Platelet-rich plasma (PRP) • Stem cells (BMAC) • FlexiGraft DBM sponge • Patch augmentation
- 34. ECM Patches • Justification – Failure rates: 20 57% reported for RC repairs – In vivo animal studies: Support use of acellular dermal grafts for augmentation – Biomechanical studies: Dermal grafts superior suture retention over SIS or BM patches • But – acellular significant DNA • GraftJacket, Restore, TissueMend Adams et al, Arthroscopy 2006. Aurura et al, J Shoulder Elbow Surg 2007. Coons et al, Sports Med Arthrosc Rev 2006.
- 35. RC Repair Augmentation • Peer reviewed clinical studies do not support SIS grafts • Iannotti et al, (JBJS 2006) - Randomized prospective controlled trial using (Restore) augmentation for massive tears showing no benefit using SIS. Discontinued study early! • Walton et al. (JBJS 2007) - 19 pts. 4 of which had severe early inflammatory rxn. 2 yr. MRI shows no difference in failure rate vs non-augmented, abandoned study early! Porcine graft (Level 3) • Schlamberg et al. (J Shoulder Elbow Surg 2004) All patients re-tore • Zheng et al. (J Biomed Mater Res B Appl Biomater 2005) Adverse outcomes related to retained cellular elements • Dermis grafts show potential • Burkhead et al. (Semin Arthroplasty 2007) 17 pts, GJA augmentation, 1.2 yrs F/U, improved UCLA scores but 3 retears per MRI & no reversal of atrophy or fatty infiltration. No Control group Iannotti et al, JBJS 2006 Walton et al, JBJS 2007 Schlamberg et al, JSES 2004 Zheng et al, J Biomed Mater Res B Appl Biomater 2005 Burkhead et al, Semin Arthroplasty 2007
- 36. ArthroFlex • Ready to use • Hydrated • Room temperature storage • Sterile (10-6 SAL) • 3 year shelf life • Biocompatible – > 97% DNA removal • Excellent suture retention strength • Intact framework
- 37. Strength Comparison: ArthroFlex vs. Other ECM Patches Barber et al, Arthroscopy 2009
- 38. DNA Residuals 273 135 16 300 250 200 150 100 50 0 Alloderm GraftJacket ArthroFlex The DNA content for the three materials averaged: Alloderm1 272.8±168.8 ng/mg; GraftJacket2 134.6 ± 44.0 ng/mg dry weight; ArthroFlex 15.97±4.8 ng/mg dry weight.3 Choe et al. J Urol. 2001. Derwin et al. JBJS-A. 2006. Data on file, LifeNet Health.
- 39. In vivo Study Devitalized Human Dermis • Preserved with 15% glycerol and gamma irradiated at delivered dose 12.8 - 17.8 kGy • Implanted subcutaneously in athymic mice – In-life period was 4 weeks • H&E Staining Post Implantation Arrows pointing to new blood vessels with red blood cells in them Lifenet. Data on file. Capito et al, Ann Plast Surg. 2012.
- 40. Placement • Dermal side – Shiny, smooth, absorbs blood – Applied in the down position against the wound or most vascularized tissue • Basement membrane – Dull and rough in appearance – Repels blood – Place in up position – Packaged in view
- 41. RCR with Graft Augmentation
- 42. SpeedBridge with ArthroFlex Augmentation
- 43. BioBridge
- 44. IRREPARABLE ROTATOR CUFF TEAR
- 45. Options for Irreparable RC Tears Traditional • Debridement • Partial repair • Biceps tenotomy • Latissimus dorsi transfer • • Reverse arthroplasty Advanced Technology • Superior Capsular Reconstruction
- 46. Disadvantages to Reverse Total Shoulder • Subject to overuse • Too easily seen as a solution for all previously untreatable shoulder pathologies • Challenging surgical technique • Requires extensive training and experience limits availability • Arthroplasty • Limited life span • Wide range of complication rates
- 47. Intercalary Placement • Biomechanical studies showing equivalent load-to-failure and mechanical properties, but few articles show success clinically Snyder et al, IJSS 2007 Schlamberg et al, JSES 2004
- 48. Bridging vs. SCR Conventional Patch Graft Superior Capsular Reconstruction Courtesy of Dr. Teruhisa Mihata
- 49. Biomechanical Effects of SCR Teruhisa Mihata, MD Initial Superior Force Mihata et al, AJSM 2012
- 50. Arthroscopic Superior Capsule Reconstruction Teruhisa Mihata, MD • Methods: • 24 shoulders over 2 years • Autograft fascia lata used to reconstruct superior capsule • Results: • A-H distance: 4.6 2.2 mm to 8.7 2.6 mm (p < 0.0001) • ASES Score: 23.5 to 92.9 points (p < 0.0001) • Twenty patients (83.3%) had no graft tear or tendon re-tear Mihata et al, Arthroscopy 2013
- 51. Harvest of Fascia Lata Teruhisa Mihata, MD
- 52. Superior Capsular Reconstruction Alan M Hirahara, MD, FRCSC Medial: Glenoid PASTA Bridge Lateral: SpeedBridge
- 53. ArthroFlex Sizes Available • AFLEX100 3.5 cm x 3.5 cm x 1.5 mm $2,225 • AFLEX101 4.0 cm x 7.0 cm x 1.5 mm $2,650 • AFLEX103 5.0 cm x 9.0 cm x 1.5 mm $3,600 • AFLEX150 1.5 cm x 14.0 cm x 1.5 mm $2,000 • AFLEX200 3.5 cm x 3.5 cm x 2.0 mm $2,975 • AFLEX201 4.0 cm x 7.0 cm x 2.0 mm $3,600 • AFLEX301 4.0 cm x 7.0 cm x 3.5 mm $3,850 • AFLEX400 4.0 cm x 4.0 cm x 1.0 mm $2,050 • AFLEX401 4.0 cm x 7.0 cm x 1.0 mm $2,500 • AFLEX500 3.0 cm x 4.0 cm x .5 mm $1,150
- 54. Biomechanical Comparison Fascia Lata, Doubled ArthroFlex, 3.5 mm Failure = 180 N Failure = 550 N
- 56. 2nd Look Terahisu Mihata, MD
- 57. Case #1 • 59 year old female • h/o R shoulder RCR x 3 • ROM – Full passive ROM – Active FF 90o • Strength – 3-/5 AH Distance = 2 mm
- 58. Surgery SCR
- 59. Radiographic Outcome 2 months post-op SCR Pre-op Post-op AH Distance = 2.0 mm AH Distance = 8.4 mm
- 60. Radiographic Outcome 2 months post-op SCR Long Axis Short Axis
- 61. Radiologic Outcome 4 months post-op SCR Normal Pre-op Post-op
- 62. Clinical Outcome 3 months post-op SCR Pre-op Post-op • VAS Scores: 5 1 • ASES Scores: 58 82 • Forward flex: 90 160
- 63. Case #2 • 61 year old male • h/o L shoulder RCR 6/13 • ROM – Full passive ROM – Active FF 10o • Strength – 3-/5 AH Distance = 3.5 mm
- 64. Surgery - SCR Before After
- 65. Radiologic Outcome 1 month post-op SCR Pre-op Post-op AH Distance = 3.5 mm AH Distance = 9.6 mm
- 66. Radiographic Outcome 1 month post-op SCR Long Axis Short Axis
- 67. Clinical Outcome 1 month post-op SCR
- 68. Case #3 AH Distance = 7.9 mm • 67 year old male • ROM – Full passive ROM – Active FF 90o • Strength – 4-/5
- 69. Surgery - SCR Before After
- 70. Radiologic Outcome 1 week post-op SCR Pre-op Post-op AH Distance = 7.9 mm AH Distance = 8.3 mm
- 71. Radiographic Outcome 1 month post-op SCR / Post Fall!!! Long Axis Short Axis
- 72. Clinical Outcome 1 month post-op SCR
- 73. Summary Mihata • Fascia lata autograft – 180 N • A-H distance – 4.6 mm to 8.7 mm • ASES Scores – 23.5 to 92.9 • 83.3% - No graft or re-tear Hirahara • ArthroFlex allograft – 550 N • A-H distance – 4.5 mm to 8.8 mm • ASES Scores – 45.3 to 82.0 • No complications yet n = 24 patients / Follow up 24-51 mos n = 3 patients / Follow up 2-4 mos
- 74. for my patients? • NO Bone Loss! • NO Large Incisions! • NO Prolonged Rehabiliation • NO Burned Bridges! • NO Reverse Prosthesis! • Less pain! • Better Function!!
- 76. Options Traditional • Reverse arthroplasty Advanced Technology • ArthroFlex resurfacing + SCR • Biologic total shoulder
- 77. The Future?
- 78. Technology has no will without someone behind the mask/curtain!
- 79. HiraharaMD.com